Paradigm Asset Management Company »

Halozyme Therapeutics shares owned by Paradigm Asset Management Company

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Paradigm Asset Management Company from 13F filings

Historical chart of Paradigm Asset Management Company investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Paradigm Asset Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Paradigm Asset Management Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0M 14k 73.34
2025-06-30 $713k 14k 52.02